Pancreatic Cancer Research

ResearcherChinese University of Hong KongActive in the last 2 years

Wan Yee Lau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6686-5440; OpenAlex author ID A5053820568. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2021: 3 papers · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 1 paper

Papers 8

  1. Real-time fluorescence-assisted semi-ex vivo intestinal autotransplantation for pancreatic adenocarcinoma patients with mesenteric root invasion (with video). Co-author DOI 10.1016/j.hbpd.2024.07.003↗
  2. Risk factors of positive resection margin differ in pancreaticoduodenectomy and distal pancreatosplenectomy for pancreatic ductal adenocarcinoma undergoing upf… Co-author DOI 10.1016/j.asjsur.2022.09.156↗
  3. Current controversies and challenges for resection of pancreatic ductal adenocarcinoma in pancreatic head aiming at cure. Co-author DOI 10.1016/j.hbpd.2022.11.009↗
  4. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study. Co-author DOI 10.1097/js9.0000000000000296↗
  5. Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study. Co-author DOI 10.1007/s00423-021-02321-7↗
  6. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.16573↗
  7. Which Factors Are Associated with Positive Resection Margin in Pancreatic Ductal Adenocarcinoma for different surgical procedures? Results Based on a Standard … Co-author DOI 10.21203/rs.3.rs-111309/v2↗
  8. Risk Factors of Positive Resection Margin Differ in Pancreaticoduodenectomy and Distal Pancreatosplenectomy For Pancreatic Ductal Adenocarcinoma: A Study Based… Co-author DOI 10.21203/rs.3.rs-963631/v1↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiming Zhao · 3 shared papers, 2021–2023 · strength 0.46
  2. Rong Liu · 3 shared papers, 2021–2023 · strength 0.46
  3. Suizhi Gao · 3 shared papers, 2021–2023 · strength 0.43
  4. Chenming Ni · 3 shared papers, 2021–2023 · strength 0.43
  5. Hui Jiang · 3 shared papers, 2021–2023 · strength 0.43
  6. Gang Li · 3 shared papers, 2021–2023 · strength 0.43
  7. Gang Jin · 3 shared papers, 2021–2023 · strength 0.43
  8. Shuai Xu · 2 shared papers, 2022–2023 · strength 0.33
  9. Xiuping Zhang · 2 shared papers, 2022–2023 · strength 0.33
  10. Bo Li · 2 shared papers, 2021–2023 · strength 0.31
  11. Xiaoyi Yin · 2 shared papers, 2021–2023 · strength 0.30
  12. Qu Liu · 2 shared papers, 2021–2022 · strength 0.27
  13. Yu Zhang · 1 shared paper, 2025 · strength 0.27
  14. Chong Yang · 1 shared paper, 2025 · strength 0.27
  15. Peng Li · 1 shared paper, 2025 · strength 0.27
  16. Xin-Yu You · 1 shared paper, 2025 · strength 0.27
  17. Xiaohan Shi · 2 shared papers, 2021 · strength 0.25
  18. Minggen Hu · 1 shared paper, 2023 · strength 0.18
  19. Nan Jiang · 1 shared paper, 2022 · strength 0.15
  20. Guanghai Dai · 1 shared paper, 2022 · strength 0.15
  21. Xiu‐Ping Zhang · 1 shared paper, 2021 · strength 0.13
  22. Yuzhen Gao · 1 shared paper, 2021 · strength 0.13
  23. Shiwei Guo · 1 shared paper, 2021 · strength 0.13
  24. Bo Li · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.